SCHEMBL14973133

SCHEMBL14973133

O=C(O)c1cnn(CF)c1CCc1ccc(C(F)(F)F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ASPH Q12797 2/20 0.41
KDM8 Q8N371 2/20 0.41
KDM4E B2RXH2 1/20 0.41
RIOX2 Q8IUF8 1/20 0.41
FFAR1 O14842 1/20 0.40
SORT1 Q99523 2/20 0.39
SRD5A2 P31213 1/20 0.39
MAPT P10636 2/20 0.39
FABP4 P15090 2/20 0.38
GUSB P08236 1/20 0.38
HPSE Q9Y251 1/20 0.38
NR3C2 P08235 1/20 0.38
KDM5A P29375 1/20 0.37
KDM4C Q9H3R0 1/20 0.37
KDM5B Q9UGL1 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
POLB P06746 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PDPK1 O15530 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14973283 0.89 MAPT (0.43) ASPHKDM8KDM4ERIOX2FFAR1
SCHEMBL14973224 0.83 MAPT (0.48) KDM4EMAPTSMN1; SMN2
SCHEMBL14973035 0.83 ASPH (0.42) ASPHKDM8KDM4ERIOX2FFAR1
SCHEMBL14972977 0.80 PPARA (0.36) ASPHKDM8KDM4ERIOX2SORT1
SCHEMBL14972983 0.75 MAPT (0.49) KDM4EMAPTSMN1; SMN2
SCHEMBL14973107 0.72 KDM4E (0.43) KDM4EMAPTNR3C2HDAC1HDAC8
SCHEMBL28150824 0.69 SRD5A2 (0.72) FFAR1SRD5A2HDAC1HDAC8PDPK1
SCHEMBL14973210 0.68 MAPT (0.50) KDM4EMAPTSMN1; SMN2
SCHEMBL14973308 0.68 PDE2A (0.38) MAPTNR3C2HDAC1HDAC8FLT1
SCHEMBL14973309 0.68 MAPT (0.43) KDM4EMAPTNR3C2HDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8877830-B2 Stress relief for crosslinked polymers THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2014-11-04 US disclosed
EP-2604602-A1 HETEROARYL-PYRAZOLE DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2013-06-19 EP disclosed
US-20130137865-A1 HETEROARYL-PYRAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2013-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137865-A1 HETEROARYL-PYRAZOLE DERIVATIVE GRIN2C, GRIN2B, GRIN3A ASPH 2766/4885KDM8 4722/4885KDM4E 4251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.